Skip to main content
. 2013 Jun 22;8(4):290–296. doi: 10.1007/s11483-013-9302-7

Table 1.

Characteristics of BA before and after the injection of solutions of metabolism inhibitors

SS 1 % DMSO MANN CB LANTR COLCH CYCL ICI 100 % DMSO
MBA ± SD 0.61±0.002a (n = 156)
BA during last 300 min. of experiment ± SD 0.626 ± 0.021a (n = 12) 0.637 ± 0.043a (n = 15) 0.607 ± 0.042a (n = 13) 0.540 ± 0.056a (n = 24) 0.492 ± 0.103b (n = 20) 0.634 ± 0.034a (n = 15) 0.722 ± 0.081a (n = 19) 0.370 ± 0.137c (n = 13) 0.163 ± 0.064d (n = 24)
Change of BA (%) +1.5 +3.24 −1.62 −12.47 −20.25 +2.75 +17.01 −40.03 −73.58
Percentage effect of individual solutions on the BA resulting only from biological processes (in relation to BA of 100% DMSO) (%) 2.04 4.4 2.2 16.96 27.53 3.74 23.12 54.40 100

The same superscript letter means no significant difference at p = 0.05. + or – in the row “Change of BA (%)” is an increase or decrease of BA after injection, respectively

MBA mean biospeckle activity before injection, SS standard solution, 1% DMSO 1% solution of dimethyl sulfoxide, MANN solution of mannitol, CB solution of cytochalasin B, LANTR solution of lantrunculin B, COLCH solution of colchicine, CYCL solution of cycloheximid, ICI solution of mixture of ion channel inhibitors, 100%DMSO 100% dimethyl sulfoxide, n number of apples examined